Videx ec and Emtriva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Videx ec (didanosine) and Emtriva (emtricitabine). Common drug interactions include pyrexia among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Videx ec and Emtriva. It is created by eHealthMe based on reports of 42 people who take the same drugs from the FDA, and is updated regularly.

What is Videx ec?

Videx ec has active ingredients of didanosine. eHealthMe is studying from 1,223 Videx ec users. Check the latest studies of Videx ec.

What is Emtriva?

Emtriva has active ingredients of emtricitabine. eHealthMe is studying from 2,383 Emtriva users. Check the latest studies of Emtriva.



On Jul, 15, 2026

42 people who take Videx ec and Emtriva together, and have interactions are studied.

Videx ec and Emtriva drug interactions.

What are the common drug interactions of Videx Ec and Emtriva, by gender? *:

female:

  1. Pyrexia (fever)
  2. Stomatitis (inflammation of mucous membrane of mouth)
  3. Blood bilirubin increased
  4. Diarrhoea
  5. Nausea (feeling of having an urge to vomit)
  6. Uterine leiomyoma (uterine benign tumour derived from smooth muscle)
  7. Vertigo
  8. Vomiting
  9. Anaemia (lack of blood)
  10. Bone loss

male:

  1. Anxiety
  2. Depression
  3. Psychomotor skills impaired
  4. Psychotic disorder
  5. Suicidal ideation
  6. Psychiatric decompensation (worsening of symptoms to the state of a serious mental disorder)
  7. Tearfulness (excess tearing)
  8. Emotional distress
  9. Pain
  10. Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the common drug interactions of Videx Ec and Emtriva, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood bilirubin unconjugated increased
  2. Dermatitis allergic (inflammation of the skin due allergic reaction)
  3. Pyrexia (fever)
  4. Stomatitis (inflammation of mucous membrane of mouth)
  5. Blood bilirubin increased

20-29:

n/a

30-39:

  1. Penile ulceration
  2. Tinea infection (fungal skin infection)
  3. Type 2 diabetes mellitus
  4. Uterine leiomyoma (uterine benign tumour derived from smooth muscle)
  5. Abortion spontaneous (naturally occurring miscarriage)
  6. Drug exposure during pregnancy
  7. Diabetic coma
  8. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  9. Diarrhoea
  10. Dyspepsia (indigestion)

40-49:

  1. Wound infection
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Emotional distress
  5. Hip arthroplasty
  6. Hypertriglyceridaemia (excess of triglycerides in the blood)
  7. Pain
  8. Renal failure (kidney dysfunction)
  9. Bone density decreased
  10. Bone loss

50-59:

  1. Anxiety
  2. Depression
  3. Depression suicidal (suicide depressive disorder)
  4. Depressive symptom
  5. Diplopia (double vision)
  6. Eyelid ptosis (falling of the upper or lower eyelid)
  7. Lipodystrophy acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired)
  8. Mitochondrial toxicity (a condition in which the mitochondria of a body's cells become damaged or decline significantly in number;)
  9. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
  10. Psychomotor retardation (motor mental retardation)

60+:

  1. Anxiety
  2. Emotional distress
  3. Injury
  4. Osteoporosis (bones weak and more likely to break)
  5. Renal impairment (severely reduced kidney function)
  6. Renal injury (kidney injury)
  7. Rib fracture
  8. Stress
  9. Depression
  10. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)

What are the existing conditions these people have? *

  1. Hiv Infection: 33 people, 78.57%
  2. Bipolar Disorder (mood disorder): 4 people, 9.52%
  3. Rashes (redness): 4 people, 9.52%
  4. Stress And Anxiety: 4 people, 9.52%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 7.14%
  6. Blood Testosterone Decreased: 3 people, 7.14%
  7. Cardiac Disorder: 3 people, 7.14%
  8. Chest Pain: 3 people, 7.14%
  9. Depression: 3 people, 7.14%
  10. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Videx ec and Emtriva?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Videx ec and Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Videx ec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emtriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Videx ec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emtriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on didanosine and emtricitabine (the active ingredients of Videx ec and Emtriva, respectively), and Videx ec and Emtriva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: